You are viewing an expired study

This study is not currently recruiting Study Participants on If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Overland Park, Kansas 66211

  • Healthy


This trial is conducted in the United States of America (USA). The purpose of this trial is to investigate the dose response to recombinant factor VIIa in healthy volunteers when administered for bleed.


Inclusion Criteria: - Ages Eligible for Study: 18 Years - 60 Years Exclusion Criteria:



Primary Contact:

Study Director
Global Clinical Registry (GCR, 1452)
Novo Nordisk A/S

Backup Contact:


Location Contact:

Overland Park, Kansas 66211
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.